Endothellal nitric oxide synthase (eNOS) enzymatically converts L-arglnlne to L-citrulline within endothelial cells. This reaction results in the release of nitric oxide (NO). N O mediates vascular smooth muscle relaxation and has been proposed to be an important regulator o f blood pressure homoeostasis during pregnancy. Our laboratory previously demonstrated an association between preeclampsia and a polymorphism (27 bp repeat) within intron 4 (1-4) of the eNOS gene (NOS)). We sought to establish whether a missense mutation (Glu298Asp) within exon 7 (E-7) o f NOS3 co-segregates with the I-4 polymorphism. We also studied the combined effect o f the NOS3 1-4 polymorphism and NOS3 E-7 mutation on clinical phenotype Method> Genomic DNA was extracted from blood o f 54 women with preeclampsia (PET) and 37 controls. Genotyping was performed by PCR (1-4) and PCR-RFLP analysis (E-7). Women with at least one NOS3 1-4 copy allele were designated A and those with the more common 5 copy were scored B Women with at least one E-7 mutation were designated M and those with no mutation were designated N . All products were scored using a 1.5% agarose gel. Results: One o f 5 women homozygous for the 1-4 A-allele also had an E-7 mutation. None o f the four women homozygous for the E-7 mutatton had the 1-4 A-allele. All women homozygous for the E-7 mutation were identified within the control group. Among women with PET, those scored as BIM Ihad significantly higher blood urea nitrogen (18.6 mgldl) when compared to those The past decade has witnessed the expansion of ultrasound technology lnto prenatal genetlc screening wlth the appl~cat~on of ultrasound for fetal aneuplo~dy rlsk assessment uslng nuchal translucency measurement It IS well accepted that promlnent separatlon of the amnlon and chorlon membranes IS a commonly observed finding ~n first trimester pregnancles However, recent work and experience have suggested that such separatlon may be assoc~ated w~t h an Increased rlsk of chromosome abnormal~ty when found In the late first and second trimesters W e thus evaluated our most recent (1997 -1999) prenatal d~agnost~c cases from 13 0 to 14 9 weeks' gestat~on. lncluslve Of the 247 cases. 14 cases (5 7%) were character~zed by an amnlon-chor~on separatlon (at any glven polnt and not necessartly unlform) of 15 m m or greater The measurement of amnion-chorlon separatlon was achleved by averaging 3 separate vlews of the membranes Of these 14 pregnancles. 6 (42 9%) were characterlzed by abnormal fetal complements 3 cases of trlsomy 21. 2 cases of trlsomy 18 and a slngle case of 45.X Of note IS that all but 2 of the cases of trlsomy 21 demonstrated concom~tant ultrasounddetected fetal structural'defects at the l~m e of ultrasound examlnatlon C o n c l u s~o n s . Our find~ngs from thls prellmlnary study demonstrate that promlnent amn~on-chor~on separatlon at or after the 13"' gestat~onal week may be assoc~ated wlth a n Increased rlsk for fetal chromosome abnormallt~es Further work IS needed to determine whether thls IS Prenatal screening has been adopted universally to prevent or at least reduce the number of chlldren born with severe congenital anomalies by idenliving women at an increased nsk over the general populat~on Specifically, prenatal screening for chromosomal d~sorders includes maternal serum markers (MSM), maternal age and history (MA) and ultraronography (US). Upon identification of increased risk. women are offered counseling and given the option of having an invasive diagnostic procedure OBJECTIVES: To evaluate the number of invasive diagnostic procedures performed after non-d~rective genetic counseling for a posltlve MSM. MA or US. MATERIAL AND METHODS: We studied 2525 pregnant women in 1995, 1996, 1997 and Jan I to Oct 3 1 1999 53 4 % o f patients were Hispanic. 30.4% Afncan American. I2 I% Caucasian and 3.9% of other ethnlc backgrounds. 1866 patients (74%) were on Medicaid or uninsured while 659 patients (26%) had their own msurance. RESULTS: Of these 2525 women. 1695 (67%) were referred due to positive prenatal screentng The remaining 830 pattents were referred for other indications: teratogenlc exposure, family history, prevlous pregnancy loss, consanguinity, etc The table shows the number of patients refelled for MSM (37%). MA (51%) and US (12%) Although the success of counseling is based solely on whether patlents are effect~vely Informed of the~r d~agnost~c and therapeut~c options, our screening outcomes strongly suggest that community and lnstttut~onal factors are respons~ble for the relati\,ely low part~cipatton In prenatal diagnostic testlng Prlman care provtders should offer lnformatlon on the objectlves of prenatal screentng. as u,ell as the nature of the lnvaslve procedures for diagnos~s and the potential consequences of havlng a child w~th spec~al needs Providing accurate ~nforrnat~on prlor to prenatal screentng and referral could potent~ally decrease the number of referrals of par~ents who are trul) uninterested In the objectlves of prenatal screenlng and d~agnosls
with a B/M score also had a slgnlficantly greater urine dip-st~ch proteln value (median 3 vs. 2 5) and higher weight on admission (201 vs. 164 Ibs) than women scored as B M . Conclusion. The 1-4 polymorphism and the E-7 mutation in NOS3 do not appear to co-segregate. The E-7 mutatton of NOS3 may have specific influences on the phenotypic features observed among women with preeclampsla.
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